These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 25800827

  • 1. Mycophenolate mofetil in primary central nervous system vasculitis.
    Salvarani C, Brown RD, Christianson TJ, Huston J, Giannini C, Miller DV, Muratore F, Hunder GG.
    Semin Arthritis Rheum; 2015 Aug; 45(1):55-9. PubMed ID: 25800827
    [Abstract] [Full Text] [Related]

  • 2. Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience.
    Salvarani C, Brown RD, Christianson TJH, Huston J, Giannini C, Hunder GG.
    Autoimmun Rev; 2020 Apr; 19(4):102497. PubMed ID: 32062032
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil as induction and maintenance immunosuppressive therapy in adult primary central nervous system vasculitis: A prospective observational study.
    Das S, Goswami RP, Sinha D, Shobhana A, Purkayastha S, Datta A.
    Clin Rheumatol; 2023 Aug; 42(8):2155-2162. PubMed ID: 37069367
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 5. Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil.
    Sen ES, Leone V, Abinun M, Forsyth R, Ramesh V, Friswell M, O'Callaghan F, Ramanan AV.
    Rheumatology (Oxford); 2010 Apr; 49(4):806-11. PubMed ID: 20100791
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 7. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 8. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Apr; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 9. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
    Stassen PM, Tervaert JW, Stegeman CA.
    Ann Rheum Dis; 2007 Jun; 66(6):798-802. PubMed ID: 17179175
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
    Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D, European Vasculitis Study Group (EUVAS).
    Ann Rheum Dis; 2019 Mar; 78(3):399-405. PubMed ID: 30612116
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 13. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Nov 24; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
    Ibernon M, Poveda R, Vidaller A, Bestard O, Grinyó JM.
    Clin Nephrol; 2008 Jun 24; 69(6):395-401. PubMed ID: 18538114
    [Abstract] [Full Text] [Related]

  • 18. Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients.
    Salvarani C, Brown RD, Christianson TJ, Huston J, Giannini C, Miller DV, Hunder GG.
    Arthritis Rheumatol; 2015 Jun 24; 67(6):1637-45. PubMed ID: 25708615
    [Abstract] [Full Text] [Related]

  • 19. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
    Ren P, Han F, Chen L, Xu Y, Wang Y, Chen J.
    Am J Nephrol; 2012 Jun 24; 36(3):271-7. PubMed ID: 22965140
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Primary Angiitis of the Central Nervous System.
    Bays AM.
    Neuroimaging Clin N Am; 2024 Feb 24; 34(1):23-29. PubMed ID: 37951702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.